Reserpine and Xenazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Reserpine (reserpine) and Xenazine (tetrabenazine). Common drug interactions include blood pressure decreased among females and convulsion among males.

The phase IV clinical study analyzes what interactions people have when they take Reserpine and Xenazine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Reserpine?

Reserpine has active ingredients of reserpine. eHealthMe is studying from 212 Reserpine users. Check the latest studies of Reserpine.

What is Xenazine?

Xenazine has active ingredients of tetrabenazine. eHealthMe is studying from 7,308 Xenazine users. Check the latest studies of Xenazine.



On Aug, 01, 2026

11 people who take Reserpine and Xenazine together, and have interactions are studied.

Reserpine and Xenazine drug interactions.

What are the common drug interactions of Reserpine and Xenazine, by gender? *:

female:

  1. Blood pressure decreased
  2. Decreased appetite
  3. Disturbance in social behaviour
  4. Emotional disorder
  5. Excoriation (to tear or wear off the skin of)
  6. Facial palsy (paralysis of face nerve)
  7. Gait disturbance
  8. Impaired work ability
  9. Insomnia (sleeplessness)
  10. Nasopharyngitis (inflammation of the nasopharynx)

male:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Dizziness
  3. Blood pressure increased
  4. Dermatitis diaper (diaper rash is a common form of inflamed skin)
  5. Eye haemorrhage (bleeding in the eye)
  6. Fall
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Abdominal hernia
  9. Arthropathy
  10. Decreased activity

What are the common drug interactions of Reserpine and Xenazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Eye disorder
  3. Feeding tube complication
  4. Lip discolouration
  5. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  6. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  7. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  8. Staphylococcal infection (an infection with staphylococcus bacteria)
  9. Dermatitis diaper (diaper rash is a common form of inflamed skin)
  10. Abdominal hernia

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Decreased appetite
  2. Disturbance in social behaviour
  3. Emotional disorder
  4. Excoriation (to tear or wear off the skin of)
  5. Facial palsy (paralysis of face nerve)
  6. Gait disturbance
  7. Impaired work ability
  8. Insomnia (sleeplessness)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Tourette's disorder (a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics)

60+:

  1. Dizziness
  2. Blood pressure inadequately controlled
  3. Joint instability (a condition in which the joints aren't sufficiently supported)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Osteomyelitis (infection of bone)
  6. Blood pressure increased
  7. Eye haemorrhage (bleeding in the eye)
  8. Fall
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Arthropathy

What are the existing conditions these people have? *

  1. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 27.27%
  2. Movement - Uncontrolled Or Slow: 3 people, 27.27%
  3. Dyskinesia (abnormality or impairment of voluntary movement): 3 people, 27.27%
  4. Tardive Dyskinesia (a disorder that involves involuntary movements): 2 people, 18.18%
  5. Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 9.09%
  6. Stress And Anxiety: 1 person, 9.09%
  7. Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 1 person, 9.09%
  8. Depression: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Reserpine and Xenazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Reserpine and Xenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Reserpine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reserpine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xenazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on reserpine and tetrabenazine (the active ingredients of Reserpine and Xenazine, respectively), and Reserpine and Xenazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: